SQA
JAZZ icon

Simon Quick Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Simon Quick Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5
Closed -$713 – 448
2019
Q2 		$713 Buy
+5
New +$672 ﹤0.01% 441
2018
Q1 		– Sell
-49
Closed -$7K – 368
2017
Q4 		$7K Hold
49
– – ﹤0.01% 349
2017
Q3 		$7K Buy
+49
New +$7.41K ﹤0.01% 447

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Simon Quick Advisors's JAZZ Position: Q3 2019 in Review

Simon Quick Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 5 shares — an estimated $713 sold.

Simon Quick Advisors first reported a position in JAZZ in Q3 2017 and held it in 3 quarters. The position peaked at $7K in Q4 2017. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • Simon Quick Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Simon Quick Advisors sold 5 Jazz Pharmaceuticals shares in Q3 2019, an estimated $713.
  • Simon Quick Advisors first reported a position in Jazz Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • Simon Quick Advisors's Jazz Pharmaceuticals position peaked at $7K in Q4 2017.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Simon Quick Advisors's 13F filing for Q3 2019, filed 16 Oct 2019.